Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $608.63 | 10 | 99.4% |
| Education | $3.85 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Exact Sciences Corporation | $115.27 | 4 | $0 (2024) |
| TherapeuticsMD, Inc. | $112.01 | 2 | $0 (2019) |
| Myriad Women's Health, Inc. | $111.65 | 1 | $0 (2023) |
| Astellas Pharma US Inc | $99.33 | 1 | $0 (2024) |
| AbbVie, Inc. | $96.51 | 2 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $77.71 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $159.19 | 3 | Astellas Pharma US Inc ($99.33) |
| 2023 | $167.06 | 3 | Myriad Women's Health, Inc. ($111.65) |
| 2019 | $112.01 | 2 | TherapeuticsMD, Inc. ($112.01) |
| 2018 | $96.51 | 2 | AbbVie, Inc. ($96.51) |
| 2017 | $77.71 | 1 | Valeant Pharmaceuticals North America LLC ($77.71) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: Oncology | ||||||
| 03/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $31.23 | General |
| Category: Oncology | ||||||
| 01/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $99.33 | General |
| Category: Biological | ||||||
| 11/09/2023 | Myriad Women's Health, Inc. | — | Food and Beverage | In-kind items and services | $111.65 | General |
| 10/04/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.80 | General |
| Category: Oncology | ||||||
| 06/14/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Oncology | ||||||
| 11/01/2019 | TherapeuticsMD, Inc. | IMVEXXY (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 08/28/2019 | TherapeuticsMD, Inc. | BIJUVA (Drug) | Food and Beverage | In-kind items and services | $87.23 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 10/26/2018 | AbbVie, Inc. | Orilissa (Drug) | Education | In-kind items and services | $3.85 | General |
| Category: Endocrinology | ||||||
| 08/30/2018 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $92.66 | General |
| Category: Endocrinology | ||||||
| 06/27/2017 | Valeant Pharmaceuticals North America LLC | ADDYI (Drug) | Food and Beverage | In-kind items and services | $77.71 | General |
| Category: OBSTETRICS, GYNECOLOGY, WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 622 | 630 | $122,450 | $42,077 |
| 2022 | 10 | 673 | 682 | $131,820 | $46,363 |
| 2021 | 8 | 500 | 505 | $90,600 | $33,996 |
| 2020 | 8 | 359 | 367 | $64,790 | $26,151 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2023 | 128 | 128 | $53,760 | $18,212 | 33.9% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 127 | 127 | $22,860 | $7,324 | 32.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 121 | 121 | $7,865 | $5,159 | 65.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 67 | 67 | $3,685 | $3,175 | 86.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 25 | $6,130 | $2,291 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 37 | $6,110 | $2,264 | 37.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 46 | 46 | $13,800 | $1,940 | 14.1% |
| 76641 | Complete ultrasound scan of 1 breast | Office | 2023 | 17 | 17 | $6,370 | $1,541 | 24.2% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 47 | 47 | $1,645 | $121.51 | 7.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 15 | $225.00 | $48.63 | 21.6% |
| 77067 | Screening mammography | Office | 2022 | 123 | 123 | $51,660 | $17,678 | 34.2% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 122 | 122 | $21,960 | $7,034 | 32.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 125 | 125 | $8,125 | $5,320 | 65.5% |
| 76641 | Complete ultrasound scan of 1 breast | Office | 2022 | 34 | 34 | $13,450 | $3,852 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 40 | $9,200 | $3,782 | 41.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 73 | 73 | $4,015 | $3,447 | 85.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 45 | $6,975 | $3,049 | 43.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 47 | 47 | $14,100 | $1,944 | 13.8% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 62 | 62 | $2,170 | $218.84 | 10.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 11 | 11 | $165.00 | $37.83 | 22.9% |
| 77067 | Screening mammography of both breasts | Office | 2021 | 90 | 90 | $37,800 | $13,414 | 35.5% |
| 77063 | Screening digital tomography of both breasts | Office | 2021 | 90 | 90 | $16,200 | $5,459 | 33.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 108 | 108 | $6,905 | $4,669 | 67.6% |
| 76641 | Ultrasound of one breast, complete | Office | 2021 | 25 | 25 | $9,375 | $3,227 | 34.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 47 | $7,215 | $3,141 | 43.5% |
About Dr. Melissa Pearlstone, M.D
Dr. Melissa Pearlstone, M.D is a Gynecology healthcare provider based in Waterbury, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447285143.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melissa Pearlstone, M.D has received a total of $612.48 in payments from pharmaceutical and medical device companies, with $159.19 received in 2024. These payments were reported across 11 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($608.63).
As a Medicare-enrolled provider, Pearlstone has provided services to 2,154 Medicare beneficiaries, totaling 2,184 services with total Medicare billing of $148,587. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Gynecology
- Location Waterbury, CT
- Active Since 07/11/2006
- Last Updated 11/16/2011
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1447285143
Products in Payments
- Cologuard Collection Kit (Device) $115.27
- Veozah (Drug) $99.33
- Lupron (Drug) $92.66
- BIJUVA (Drug) $87.23
- ADDYI (Drug) $77.71
- IMVEXXY (Drug) $24.78
- Orilissa (Drug) $3.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.